From Name:
From Email:
To Name:
To Email:

Optional Message:


Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

from PLoS One

It is important to identify patients who are refractory to transarterial chemoembolization (TACE), which is performed for the treatment of hepatocellular carcinoma (HCC). We investigated the predictors of poor treatment outcomes in patients with recurrent HCC treated who were treated with TACE after curative resection. More than two TACE procedures within six months might be associated with the refractoriness to TACE in patients with recurrent HCC after curative resection. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063